AbuseLedger — Signup, Trial & Entitlement Abuse OS for AI-Native Products
Self-serve AI businesses increasingly have a margin problem that hides behind apparently healthy signups.
The Problem
Self-serve AI businesses increasingly have a margin problem that hides behind apparently healthy signups.
The issue is not only stolen cards or chargebacks. It is a broader wave of first-party abuse:
- people opening repeated accounts,
- reusing trials,
- farming promotional credits,
- spinning up API access for expensive inference,
- and claiming refunds after value has already been consumed.
Most teams still manage this through disconnected tools:
- auth and bot checks at signup,
- payment risk tools at checkout,
- product logs for usage,
- support tools for appeals,
- and finance spreadsheets for loss estimation.
That leaves no strong operating layer between identity, payment method, entitlement access, and compute consumption.
The opportunity is to build the abuse-control plane for self-serve AI and SaaS economics.
Ready to build this?
This idea scored 80/100. Get tomorrow's in your inbox, free, no account needed.
Related Ideas
CasaCuidados PT — Comprehensive Home Maintenance & Aging-in-Place Services
Portugal faces an unprecedented demographic crisis with 24.3% of its population over 65 and rising to 34% by 2050, while simultaneously struggling with a severely aging housing stock where 35.8% of buildings require repairs. This creates a perfect storm where the most vulnerable population—elderly h
VerdeFresh PT — Urban Microgreens & Specialty Herb Farm
Portuguese restaurants, health food stores, and conscious consumers struggle to source fresh, local microgreens and specialty herbs year-round. Current supply relies heavily on imports from Netherlands/Spain with 2-5 day transport times, resulting in reduced nutritional value and higher costs. The g
Opportunity #2: ResiduoPro PT — B2B Specialized Waste Management for Food Service
Portuguese restaurants and hotels face an escalating food waste crisis compounded by evolving regulations. Current challenges: